ECOR Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 16:00):

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies...

Stats
Today's Volume	7 234.00
Average Volume	10 354.00
Market Cap	33.97M
EPS	$0 ( 2024-03-13 )
Next earnings date	( $-0.500 ) 2024-05-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.650
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-16	Goldberger Daniel S	Buy	75 000	Common Stock
2024-01-12	Posner Brian M	Buy	16 000	Common Stock
2024-01-01	Theofilos Charles Steve	Buy	25 210	Common Stock
2023-12-08	Theofilos Charles Steve	Sell	0	Common Stock
2023-12-08	Theofilos Charles Steve	Buy	0	Common Stock

INSIDER POWER
100.00
Last 93 transactions
Buy: 5 593 347 \| Sell: 60 242

electroCore, Inc. Correlation

10 Most Positive Correlations
RING	0.919
IGLD	0.895
RGLD	0.864
BSCT	0.85
SLQD	0.841
ISTB	0.841
BSCS	0.837
INTC	0.837
BSCQ	0.833
IGSB	0.832

10 Most Negative Correlations
CINC	-0.854
BPOPN	-0.829
OBT	-0.823
CELC	-0.82
LUNA	-0.813
WSC	-0.811
GETVV	-0.808
INSE	-0.807

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

electroCore, Inc. Financials

Annual	2023
Revenue:	$16.03M
Gross Profit:	$13.23M (82.51 %)
EPS:	$-3.42

Q4	2023
Revenue:	$5.19M
Gross Profit:	$4.09M (78.81 %)
EPS:	$-0.610

Q3	2023
Revenue:	$4.51M
Gross Profit:	$3.85M (85.34 %)
EPS:	$-0.680

Q2	2023
Revenue:	$3.55M
Gross Profit:	$2.97M (83.53 %)
EPS:	$-1.030

Financial Reports:

No articles found.

electroCore, Inc.

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.